P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS.

MLA

Cassieri, C., et al. “P.07.13 Four-Year Efficacy and Safety of Azathioprine Treatment in the Maintainance of Steroid-Free Remission in Inflammatory Bowel Disease Patients.” Digestive & Liver Disease, vol. 48, Feb. 2016, p. e162. EBSCOhost, https://doi.org/10.1016/S1590-8658(16)30229-8.

APA

Cassieri, C., Pica, R., Avallone, E. V., Brandimarte, G., Zippi, M., Crispino, P., De Nitto, D., Corrado, C., Vernia, P., Paoluzi, P., & Corazziari, E. S. (2016). P.07.13 Four-Year Efficacy and Safety of Azathioprine Treatment in the Maintainance of Steroid-Free Remission in Inflammatory Bowel Disease Patients. Digestive & Liver Disease, 48, e162. https://doi.org/10.1016/S1590-8658(16)30229-8

Chicago

Cassieri, C., R. Pica, E.V. Avallone, G. Brandimarte, M. Zippi, P. Crispino, D. De Nitto, et al. 2016. “P.07.13 Four-Year Efficacy and Safety of Azathioprine Treatment in the Maintainance of Steroid-Free Remission in Inflammatory Bowel Disease Patients.” Digestive & Liver Disease 48 (February): e162. doi:10.1016/S1590-8658(16)30229-8.